Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
China Puts NRDL Negotiation, Medical Consortium and Hospital Reform in Spotlight...
Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on CFDA's latest push of healthcare reform and drug regulato... (5/1/2017)
   
Three Supreme Court Cases On Pharmaceutical Patents in China (5/25/2017)
Merck's Gardasil Preps for Head-To-Head with GSK’s Cervarix in China, With Big Sales Targets Ahead (5/24/2017)
For Millions of Chinese with Rare Diseases, Some Relief in Sight (5/19/2017) (free)
China's FDA Aims to Speed Drug OKs with Shift To U.S.-Style Clinical Trial Application Process (5/18/2017)
Winning in China's HCV Travails (5/17/2017)
Big Pharma Hopes Rule Change Will Ease China Sales Pain (5/16/2017)
From Imitator to Innovator (5/5/2017)
Pharmaceuticals Distribution in China: A Guide to the New Two Invoices System (5/5/2017)
China Launches New Two-Invoice System in Pharma Distribution (5/1/2017)
China Puts NRDL Negotiation, Medical Consortium and Hospital Reform in Spotlight, as It Gives CFDA More Teeth (5/1/2017)
Brighter Prospects for Patent Protection in China (4/27/2017)
Vitamin C Antitrust Case Could Trip Trump Up On Trade (4/27/2017)
China's New Foreign Drug Proposal: Pharmas Excited, Analysts Cautious (4/26/2017)
China's Healthcare Reforms: Double-Edged Sword For The Pharmaceutical Industry (4/25/2017)
Generic Consistency Evaluation in China: The Coming Paradigm Shift In Drug Pricing And Patent Cliff (4/20/2017)
Hengrui's Breast Cancer Candidate Shows ...  (5/26/2017)
Celltrion Granted China's First Approval...  (5/26/2017)
Stainwei Biotech's Novel Humanized Anti-...  (5/26/2017)
Chinese OTC Cough, Cold and Allergy Mark...  (5/26/2017)
Financial Overview of Urban and Rural BM...  (5/26/2017)
CFDA Solicits Comments on Measures Relat...  (5/25/2017)
Avacta Group Announces Key Affimer Paten...  (5/24/2017)
WuXi Biologics Sets Stage for $513M IPO ...  (5/24/2017)
BGI Establishes Innovation Center in the...  (5/24/2017)
Athenex and Its Chinese Partner Announce...  (5/24/2017)
Recent Executive Moves  (5/24/2017)
CFDA Issues Announcement for Handling of...  (5/24/2017)
CFDA Designates 256 More Institutions fo...  (5/24/2017)
CFDA Issues 2016 Food and Drug Regulator...  (5/24/2017)
U.S. FDA Warns Chinese API Producer for ...  (5/24/2017)
Fresenius Steps Up Pharma M&A with Akorn, Merck ...
Global Pharmerging Market to Grow at a CAGR of 12.88% in...
PhRMA Urges USTR to Protect US Innovation Abroad
Trump Wants Big Pharma Cut Outsourcing and Prices, Promi...
Mergermarket: Global Pharma and Biotech M&A Feels th...
Chinese OTC Cough, Cold and Allergy Market Posted 6% Growth in ...
Chinese MHP Trade Underlined by Strong Import Growth in Q1
SMEI Release Data Set on Chinese Drug Terminal Market 2010-2016...
Nicholas Hall Projects Chinese OTC Drug Market to Grow 6% CAGR ...
Nicholas Hall Reports 6% Growth for Chinese OTC VMS Market in 2...
Celltrion Granted China's First Approval for Biosimilar Clin...
WuXi Biologics Sets Stage for $513M IPO in Hong Kong
BGI Establishes Innovation Center in the U.S. West Coast to ...
CANbridge Life Sciences Raises $25 Million in Series B Round...
Frontline BioVentures, WuXi Healthcare To Merge, Creating $8...
CFDA Solicits Comments on Measures Relating to Equivalen...
CFDA Issues Announcement for Handling of Relevant Issues...
CFDA Designates 256 More Institutions for Clinical Resea...
CFDA Issues 2016 Food and Drug Regulatory Statistics Ann...
CDE Publicizes Batch 17 of Drug Applications To Be Grant...
DSM Sinochem Wins Indian Patent Lawsuit against Sinopharm We...
I-MAK Challenges Gilead's Remaining Patents of HCV Drug Sofo...
China, India Named and Shamed by USTR on Lax IP
PhRMA Criticizes China Over Failure to Uphold Data Exclusivi...
China to Introduce Interpretations for Application of Crimin...
U.S. FDA Warns Chinese API Producer for Absence of Writt...
India to Make Key APIs to Reduce Dependence on China
DSM Sinochem Pharmaceuticals Boosts Manufacturing Capaci...
U.S. FDA Raises Concerns over Teva's Plant In China
U.S. FDA Warns Jinda Pharma for Data Integrity Violation...
Hengrui's Breast Cancer Candidate Shows Promise in an Ea...
Stainwei Biotech's Novel Humanized Anti-VEGF mAb Receive...
Avacta Group Announces Key Affimer Patent to be Granted ...
Athenex and Its Chinese Partner Announce CFDA IND Approv...
A Dual-Functional GLP-1 Analogue May Improve Insulin Sen...
Financial Overview of Urban and Rural BMI Programs in 20...
Nippon Life Offers Cancer Insurance in China
China's Big Data Regulation to Boost Healthcare, Securit...
MOF: Chinese Fiscal Budget for Healthcare Spending to Re...
State Council Issues Document on Major Healthcare Reform...
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Former Senior CFDA Official Handed Ten Years Prison Senten...
Recent Executive Moves
Upcoming Event: Risk Management in Clinical Practice: To...
Upcoming Event: Innovation Prize 2017
Upcoming Event: 8th Annual Clinical Trials 2017
Upcoming Event: International Pharma Supply Chain Confab...
Upcoming Event: Pharma China Annual Forum 2017 in Shangh...
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links